110 related articles for article (PubMed ID: 1852759)
1. [Synthesis of a potential metabolite of the carcinostatic bendamustin (Cytostasen)].
Werner W; Letsch G; Ihn W; Sohr R; Preiss R
Pharmazie; 1991 Feb; 46(2):113-4. PubMed ID: 1852759
[TBL] [Abstract][Full Text] [Related]
2. Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride.
Teichert J; Baumann F; Chao Q; Franklin C; Bailey B; Hennig L; Caca K; Schoppmeyer K; Patzak U; Preiss R
Cancer Chemother Pharmacol; 2007 May; 59(6):759-70. PubMed ID: 16957931
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of a nitrogen mustard derivative stabilized by apo-neocarzinostatin.
Urbaniak MD; Bingham JP; Hartley JA; Woolfson DN; Caddick S
J Med Chem; 2004 Sep; 47(19):4710-5. PubMed ID: 15341486
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of cyclic nitrogen mustards based on carnitine framework.
Leiris S; Lucas M; Dupuy d'Angeac A; Morère A
Eur J Med Chem; 2010 Sep; 45(9):4140-8. PubMed ID: 20615582
[TBL] [Abstract][Full Text] [Related]
5. [Enzymatically decomposable specific transport forms of cancerostatics. 2. Chloro-substituted 4-[N,N-bis-(2-chlorethyl)-amino[-phenyl-O-beta-D-glucopyranosides and -Xylopyranosides].
Schwabe K; Graffi A
Pharmazie; 1975 Feb; 30(2):70-4. PubMed ID: 238226
[No Abstract] [Full Text] [Related]
6. Synthesis and characterization of some new phase II metabolites of the alkylator bendamustine and their identification in human bile, urine, and plasma from patients with cholangiocarcinoma.
Teichert J; Sohr R; Baumann F; Hennig L; Merkle K; Caca K; Preiss R
Drug Metab Dispos; 2005 Jul; 33(7):984-92. PubMed ID: 15845750
[TBL] [Abstract][Full Text] [Related]
7. Identification of metabolism pathways of anticancer drugs by high-pressure liquid chromatography in combination with field desorption mass spectrometry.
Przybylski M
Arzneimittelforschung; 1982; 32(9):995-1012. PubMed ID: 6756419
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics of bendamustin (Cytostasan) in B6D2F1-mice].
Weber H; Amlacher R; Preiss R; Hoffmann H
Pharmazie; 1991 Aug; 46(8):589-91. PubMed ID: 1798713
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis and antitumor action of N,N-di(2-chlorethyl)-hydrazines of alpha-aminocarboxylic acid antimetabolites].
Zakhariev S; Golovinsky E; Stoev S; Maneva L; Aleksiev B
Pharmazie; 1989 Aug; 44(8):542-4. PubMed ID: 2594824
[TBL] [Abstract][Full Text] [Related]
10. Nitro analogues of chlorambucil as potential hypoxia-selective anti-tumour drugs.
Palmer BD; Wilson WR; Denny WA
Anticancer Drug Des; 1990 Nov; 5(4):337-49. PubMed ID: 2291774
[TBL] [Abstract][Full Text] [Related]
11. HPLC study on the stability of bendamustine hydrochloride immobilized onto polyphosphoesters.
Pencheva I; Bogomilova A; Koseva N; Obreshkova D; Troev K
J Pharm Biomed Anal; 2008 Dec; 48(4):1143-50. PubMed ID: 18926656
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and mechanisms of action of bendamustine: rationales for combination therapies.
Gandhi V
Semin Oncol; 2002 Aug; 29(4 Suppl 13):4-11. PubMed ID: 12170425
[TBL] [Abstract][Full Text] [Related]
13. [Tumour chemotherapy. XXXIX Synthesis of 2-methyl-5-bis (beta-chloroethyl) aminophenylalanine and 2-bis (beta-chloroethyl)-aminomethyl-5-nitrophenylalanine (author's transl)].
Zheng YY; Ren YF
Yao Xue Xue Bao; 1979 Nov; 14(11):676-81. PubMed ID: 552207
[No Abstract] [Full Text] [Related]
14. [Synthesis and in vivo antitumor effect of N,N-di(2-chlorethyl) hydrazides of natural alpha-aminocarboxylic acids].
Zakhariev S; Stoev S; Aleksiev B; Maneva L; Golovinsky E
Pharmazie; 1989 Sep; 44(9):608-11. PubMed ID: 2514434
[TBL] [Abstract][Full Text] [Related]
15. Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems.
Niculescu-Duvaz I; Scanlon I; Niculescu-Duvaz D; Friedlos F; Martin J; Marais R; Springer CJ
J Med Chem; 2004 May; 47(10):2651-8. PubMed ID: 15115406
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of substituted naphthalimide nitrogen mustards as rationally designed anticancer compounds.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Quazi GN; Sanyal U
Acta Pol Pharm; 2003; 60(4):285-91. PubMed ID: 14714857
[TBL] [Abstract][Full Text] [Related]
17. Bis(dialkyl)dithiocarbamato cobalt(III) complexes of bidentate nitrogen mustards: synthesis, reduction chemistry and biological evaluation as hypoxia-selective cytotoxins.
Ware DC; Palmer HR; Pruijn FB; Anderson RF; Brothers PJ; Denny WA; Wilson WR
Anticancer Drug Des; 1998 Mar; 13(2):81-103. PubMed ID: 9524553
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxic activity of a glucuronylated prodrug of nornitrogen mustard.
Papot S; Combaud D; Bosslet K; Gerken M; Czech J; Gesson JP
Bioorg Med Chem Lett; 2000 Aug; 10(16):1835-7. PubMed ID: 10969980
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of the intramolecular cyclization of bis(2-chlorethyl)aminoethyl esters of carboxylic acids.
Natcheva R; Manolov I; Golovinsky EV
Pharmazie; 1986 Sep; 41(9):642-4. PubMed ID: 3797454
[TBL] [Abstract][Full Text] [Related]
20. [Research on compounds with antiblastic activity. XLI. Synthesis of new nitrogen mustards correlated with N,N-bis-(beta-chlorethyl) aniline].
Artico M; Filacchioni G; Vomero S
Farmaco Sci; 1971 Sep; 26(9):805-11. PubMed ID: 5157547
[No Abstract] [Full Text] [Related]
[Next] [New Search]
